News

With 18 new peer-reviewed articles from members of our faculty, August 2020 was a record-breaking month for the Duke Neurology Department. Clinical research highlights published in the past 31 days include an analysis of patients presenting with vertigo in Emergency Departments, an essay on the human cost of COVID-19 and how we can help people connect during difficult times, and a study finding new benefits for therapies for myasthenia gravis.

Brian Mac Grory, MD, was a second-year resident when a new method of treating stroke revolutionized vascular neurology almost overnight. Now, as a new member of our faculty, he’s treating patients with strokes and co-creating a multidisciplinary clinic specializing in treating patients who’ve suffered strokes that affect their eyes. In this week’s spotlight interview, Mac Grory talks about what he enjoys in each of these areas, how Duke is poised to help patients with eye strokes, and how he sees treatment for strokes improving in the future.

Members of the Duke Neurology Department contributed to 14 new peer-reviewed articles published this July, improving our understanding of neuroscience, charting a course for research in a post-COVID-19 world, and offering opportunities for advancing patient care. Simon Gregory, PhD, and Yong Chen, PhD, respectively co-authored articles offering new therapeutic avenues for muscle repair and chronic pain treatment. Wuwei “Wayne” Feng, MD, MS, was part of a consortium examining the impact of COVID-19 on the NIH’s StrokeNet and offering a vision for resuming clinical trials.

New research from the Duke Neurology Department advanced our understanding of neurological diseases and patient care at the basic science, translational, and clinical levels. Among other topics, our faculty, trainees, and staff found evidence for virtual reality’s potential in neurorehabilitation, tested a wearable device that can help better identify seizures, and reviewed how our understanding of the hippocampus has evolved over the past generation.

In May 2020, members of the Duke Neurology Department contributed to nine new peer-reviewed journal articles. At the clinical level, a new study protocol will test the safety of a promising drug for reducing the consequences neural inflammation, while another shares more than a decade of knowledge about improving patient engagement in ALS research. Other studies, meanwhile, answered questions about how our brains and minds function, such as a NeuroImage study that found older and younger adults used different regions of the brain when performing the same task.

Members of the Duke Neurology Department continued to advance the fields of clinical and translational neuroscience this April. Our faculty contributed to the first major systematic review of self-management programs for epilepsy, helping to answer questions about what makes these programs more or less effective. Another article discussed the benefits of CN-105, a therapeutic agent that may help reduce the harmful neuro-inflammatory response associated with stroke, traumatic brain injury, and other conditions.

What do a genetic analysis of the intersecting pathways between Alzheimer’s disease and depression, a national prize-winning essay examining the ethics of unionization for physicians, and a systematic review of the literature surrounding a new potential form of therapy for stroke recovery have in common? They’re all subjects of peer-reviewed journal articles written or co-written by members of the Neurology Department published this March.

This February, members of the Duke Department of Neurology contributed to 10 new research articles in peer-reviewed journals. At the microscopic level, new studies examined how ion channels in endothelial cells may contribute to hypertension associated with obesity, and reviewed how DNA damage contributes to neuronal death in Parkinson’s disease. And at the system-wide level, our Stroke team discussed the massive IMPROVE Stroke Care project, which includes a network of nearly 100 hospitals, and hundreds of other agencies and communities.

The AHA/ASA's top award for all three of our hospitals, as well as more than a dozen new lectures, abstracts, and presentations are just some highlights to come from Duke at the 2020 International Stroke Conference in Los Angeles this week.

Taewon Kim, PhD, first became interested in the neurosciences while playing high school baseball, when he began wondering how his brain retained the motor skills he picked up during hours of practice. Now, as a postdoctoral associate within the laboratory of Wayne Feng, MD, MD he’s helping to investigate how to help patients keep and build on those same motor skills after they’ve had a stroke. In this week’s “spotlight” interview, Kim talks to us about his graduate studies, his work at Duke, and his plans to continue academic research in the future.